SPRO·84833T103·US·equity·Healthcare - Biotechnology-Activist
SPRO (SPERO THERAPEUTICS INC) is held by 31 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($2.8M), Alphabet Inc. ($2.1M), TWO SIGMA INVESTMENTS, LP ($2.1M). Net institutional sentiment: Mixed.
See how SPRO's score breaks down across 4 SEC sources
Showing 1-20 of 39
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer